Weancare-domus ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
6. Parkinson disease
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04983290 (ClinicalTrials.gov) | November 1, 2021 | 9/6/2021 | Outcomes to the Nutritional Need of Patients With Parkinson's Disease | Clinical Trial to Assess the Effectiveness of the Food Plan Consisting of Products With Modified Consistency Called (Weancare-Domus) in Changing the Quality of Life in Patients With Parkinson's Disease | Deglutition Disorders;Parkinson Disease;Nursing;Quality of Life | Dietary Supplement: weancare-domus | Milko Zanini | Azienda Sanitaria Locale 3 Genovese | Not yet recruiting | 18 Years | N/A | All | 140 | N/A | Italy |